However, in this study, we looked at the associations of myostatin with more commonly used blood test variables and body mass indices (BMIs) for HCC risk; thus, we suggested a promising prognostic role for serum myostatin levels in HCC risk stratifications. Here, MSTN is linked to hepatocellular carcinoma.